Published: Sep 15, 2023, 04:10 IST | Updated: Sep 15, 2023, 04:10 IST
A T-cell epitope cancer vaccine significantly improved overall survival in non-small cell lung cancer (NSCLC) compared to chemotherapy, Phase III data published in Annals of Oncology has shown.